Vergent Bioscience

Minneapolis, MN · Founded 2013 · Privately Held (backing)

Developer of molecular imaging probes designed for the diagnosis and removal of cancer cells. Vergent Bioscience is based in Minneapolis, MN and was founded in 2013. It was valued at $75 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $56.4 million across 5 recorded rounds; the latest was an $18.7 million early-stage round in Oct 2025.

PMV mark · valuation
$75.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$56.4M
Last round
Early Stage VC
Oct 2025
How much has Vergent Bioscience raised?
$56.4Macross 5 recorded rounds · May 2018 – Oct 2025

Most recently, Vergent Bioscience raised $18.7M in its Early Stage VC (Oct 2025).

Free account
More of Vergent Bioscience with a free account
  • ·Watch Vergent Bioscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Vergent Bioscience round by round

5 rounds
Oct 2025Early Stage VC$18.7MSEC filing▮
20 investors participated
Feb 2025Seed Round$3.8MSEC filing▮
5 investors participated
Aug 2022Early Stage VC$21.5MSEC filing▮
27 investors participated
Nov 2021Seed Round$1.2MSEC filing▮
16 investors participated
May 2018Early Stage VC$11.9MSEC filing▮
21 investors participated

How much has Vergent Bioscience raised?

Vergent Bioscience has raised $56.4 million across 5 recorded rounds since 2018. The largest was a $3.8 million seed round in Feb 2025; the most recent was an $18.7 million early-stage round in Oct 2025.

Vergent Bioscience has filed 7 Form Ds with the SEC since 2018, most recently in Feb 2025 ($3.8 million sold to 5 investors).

Vergent Bioscience investors

7 investors are on record for Vergent Bioscience, including National Institutes of Health, Spring Mountain Capital, Colle Capital Partners and Intuitive Surgical. The early-stage round in Oct 2025 drew 20 investors.

For fundraisers
Raising for a company like Vergent Bioscience?

7 investors have backed Vergent Bioscience.

See all 7 investors →

Frequently asked about Vergent Bioscience

How much has Vergent Bioscience raised?
Vergent Bioscience has raised $56.4M in total across 5 recorded funding rounds.
When was Vergent Bioscience's last funding round?
Vergent Bioscience's most recent recorded round was Early Stage VC in Oct 2025, raising $18.7M.